Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.
Piel FB, Rees DC, DeBaun MR, Nnodu O, Ranque B, Thompson AA, Ware RE, Abboud MR, Abraham A, Ambrose EE, Andemariam B, Colah R, Colombatti R, Conran N, Costa FF, Cronin RM, de Montalembert M, Elion J, Esrick E, Greenway AL, Idris IM, Issom DZ, Jain D, Jordan LC, Kaplan ZS, King AA, Lloyd-Puryear M, Oppong SA, Sharma A, Sung L, Tshilolo L, Wilkie DJ, Ohene-Frempong K. Piel FB, et al. Among authors: tshilolo l. Lancet Haematol. 2023 Aug;10(8):e633-e686. doi: 10.1016/S2352-3026(23)00096-0. Epub 2023 Jul 11. Lancet Haematol. 2023. PMID: 37451304 Review. No abstract available.
Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial.
Aygun B, Lane A, Smart LR, Santos B, Tshilolo L, Williams TN, Olupot-Olupot P, Stuber SE, Tomlinson G, Latham T, Ware RE; REACH Investigators. Aygun B, et al. Among authors: tshilolo l. Lancet Haematol. 2024 Apr 30:S2352-3026(24)00078-4. doi: 10.1016/S2352-3026(24)00078-4. Online ahead of print. Lancet Haematol. 2024. PMID: 38701812
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial.
Power-Hays A, Tomlinson GA, Tshilolo L, Santos B, Williams TN, Olupot-Olupot P, Smart LR, Aygun B, Lane A, Stuber SE, Latham T, Ware RE. Power-Hays A, et al. Among authors: tshilolo l. Am J Hematol. 2024 Apr;99(4):625-632. doi: 10.1002/ajh.27244. Epub 2024 Feb 8. Am J Hematol. 2024. PMID: 38332651 Clinical Trial.
Access to opioid analgesics for medical use at hospital level in the Democratic Republic of Congo: An exploratory mixed-method study.
Zandibeni J, de Béthune X, Debethel Bitumba J, Mantempa J, Tshilolo L, Ndona J, Kabemba Mbaya A, Kabamb Kabey D, Mubeneshayi Kananga A, Ravinetto R. Zandibeni J, et al. Among authors: tshilolo l. Trop Med Int Health. 2023 Jan;28(1):53-63. doi: 10.1111/tmi.13837. Epub 2022 Dec 19. Trop Med Int Health. 2023. PMID: 36480447 Free PMC article.
62 results